Illumina-Grail challenge by US FTC is first effort to block a merger under US President Joe Biden
The US Federal Trade Commission today voted unanimously to file a lawsuit seeking to block Illumina’s proposed acquisition of Grail, a company that develops blood tests to identify early stage cancers,...To view the full article, register now.
Already a subscriber? Click here to view full article